Neisseria meningitidis

Neisseria meningitidis
source
Name	Neisseria meningitidis
Domain	Bacteria
Phylum	Proteobacteria
Class	Betaproteobacteria
Order	Neisseriales
Family	Neisseriaceae
Genus	Neisseria
Species	N. meningitidis

Neisseria meningitidis is a Gram-negative bacterium that is a major cause of meningitis and septicemia, particularly in children and young adults, as noted by Centers for Disease Control and Prevention and World Health Organization. It is often associated with outbreaks in Africa, Asia, and Europe, as reported by European Centre for Disease Prevention and Control and National Institute of Allergy and Infectious Diseases. The bacterium is typically spread through respiratory droplets and can be found in the nasopharynx of asymptomatic carriers, such as those studied by University of Oxford and Harvard University. Research on Neisseria meningitidis has been conducted by National Institutes of Health and Bill and Melinda Gates Foundation.

● Introduction

Neisseria meningitidis is a significant public health concern, with outbreaks occurring in Sahel region of Africa, China, and India, as documented by World Health Organization and Centers for Disease Control and Prevention. The bacterium is a leading cause of meningitis and septicemia in children and young adults, with a high mortality rate if left untreated, as noted by American Academy of Pediatrics and Society for Healthcare Epidemiology of America. Vaccination efforts have been implemented by Gavi, the Vaccine Alliance and UNICEF to control the spread of the disease. Researchers at University of California, Berkeley and Massachusetts Institute of Technology have made significant contributions to the understanding of Neisseria meningitidis.

● Microbiology

The microbiology of Neisseria meningitidis involves the study of its cell wall composition, membrane structure, and metabolic pathways, as investigated by Stanford University and University of Cambridge. The bacterium is a Gram-negative diplococcus with a polysaccharide capsule that plays a crucial role in its virulence, as described by Journal of Bacteriology and Infection and Immunity. Serogrouping is used to classify Neisseria meningitidis into different serogroups, such as serogroup A, serogroup B, and serogroup C, as reported by Centers for Disease Control and Prevention and European Centre for Disease Prevention and Control. Researchers at University of Toronto and University of Melbourne have studied the genetics of Neisseria meningitidis.

● Pathogenesis

The pathogenesis of Neisseria meningitidis involves the adhesion of the bacterium to the nasopharyngeal mucosa, followed by invasion of the bloodstream and central nervous system, as described by Nature Reviews Microbiology and Science. The bacterium produces virulence factors such as lipopolysaccharide and porins that contribute to its pathogenicity, as investigated by University of Chicago and Duke University. The host immune response plays a crucial role in determining the outcome of infection, with cytokines such as tumor necrosis factor-alpha and interleukin-1 beta involved in the inflammatory response, as reported by Journal of Immunology and Infection and Immunity. Researchers at University of California, Los Angeles and Columbia University have studied the molecular mechanisms of Neisseria meningitidis.

● Epidemiology

The epidemiology of Neisseria meningitidis involves the study of the distribution and determinants of infection in populations, as investigated by Centers for Disease Control and Prevention and World Health Organization. Outbreaks of meningitis and septicemia caused by Neisseria meningitidis have been reported in Africa, Asia, and Europe, with serogroup A being the most common cause of outbreaks in Africa, as documented by African Journal of Microbiology Research and European Journal of Epidemiology. Vaccination efforts have been implemented by Gavi, the Vaccine Alliance and UNICEF to control the spread of the disease. Researchers at University of London and University of Sydney have studied the epidemiology of Neisseria meningitidis.

● Clinical_Manifestations

The clinical manifestations of Neisseria meningitidis infection include meningitis, septicemia, and septic shock, as described by New England Journal of Medicine and Lancet. Symptoms of meningitis include fever, headache, and stiff neck, while septicemia can cause fever, chills, and hypotension, as reported by Journal of Infectious Diseases and Critical Care Medicine. Diagnosis is typically made by culture of cerebrospinal fluid or blood, as investigated by University of Washington and University of Pennsylvania. Researchers at University of California, San Francisco and Johns Hopkins University have studied the clinical manifestations of Neisseria meningitidis.

● Prevention_and_Treatment

Prevention and treatment of Neisseria meningitidis infection involve vaccination and antibiotic therapy, as recommended by Centers for Disease Control and Prevention and World Health Organization. Vaccines are available against serogroups A, B, and C, and are recommended for children and young adults, as documented by American Academy of Pediatrics and Society for Healthcare Epidemiology of America. Antibiotic therapy typically involves the use of penicillin or ceftriaxone, as reported by Journal of Antimicrobial Chemotherapy and Clinical Infectious Diseases. Researchers at University of Michigan and University of Wisconsin–Madison have studied the prevention and treatment of Neisseria meningitidis. Category:Bacteria